These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 13684568)

  • 1. In vitro susceptibility of 24 strains of Histoplasma capsulatum to amphotericin B.
    ARTIS D; BAUM GL
    Antibiot Chemother (Northfield); 1961 Jun; 11():373-6. PubMed ID: 13684568
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of mycostatin and fungizone on the growth of Histoplasma capsulatum in tissue culture.
    HOWARD DH
    J Bacteriol; 1960 Mar; 79(3):442-9. PubMed ID: 14403436
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of the antifungal agent X-5079C on the growth of Histoplasma capsulatum in vitro.
    LONES GW; PEACOCK CL
    Am Rev Respir Dis; 1961 Oct; 84():529-33. PubMed ID: 13763314
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of amphotericin B on Histoplasma capsulatum infection in the rabbit ear chamber.
    PROCKNOW JJ; RAY CG
    J Lab Clin Med; 1962 Mar; 59():496-508. PubMed ID: 14488874
    [No Abstract]   [Full Text] [Related]  

  • 5. [In vitro sensitivity of Histoplasma capsulatum var. capsulatum to amphotericin B, ketoconazole, itroconazole and fluconazole].
    Andreu CM; León AM; Medina YE; Machín GM; Lancha MR; Zaragozí MT
    Rev Cubana Med Trop; 2003; 55(2):76-82. PubMed ID: 15849960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro inhibitory effect of miltefosine against strains of Histoplasma capsulatum var. capsulatum and Sporothrix spp.
    Brilhante RS; Malaquias AD; Caetano EP; Castelo-Branco Dde S; Lima RA; Marques FJ; Silva NF; Alencar LP; Monteiro AJ; Camargo ZP; Bandeira Tde J; Rodrigues AM; Cordeiro Rde A; Moreira JL; Sidrim JJ; Rocha MF
    Med Mycol; 2014 Apr; 52(3):320-5. PubMed ID: 24662247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism of amphotericin B and 2-deoxyglucose against Histoplasma capsulatum yeasts in vitro.
    Berliner MD
    Microbios; 1975; 12(50):209-18. PubMed ID: 1160617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphotericin B potentiation of rifampicin as an antifungal agent against the yeast phase of Histoplasma capsulatum.
    Kobbayashi GS; Medoff G; Schlessinger D; Kwan CN; Musser WE
    Science; 1972 Aug; 177(4050):709-10. PubMed ID: 5054147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of organic sulfur compounds on Histoplasma capsulatum.
    McVeigh I; Evans Z; Field L; Hanley W
    Mycopathol Mycol Appl; 1969 May; 37(4):349-56. PubMed ID: 5797624
    [No Abstract]   [Full Text] [Related]  

  • 10. [Histoplasmosis (infection with Histoplasma capsulatum, capsulatum variety)].
    Pădeanu V; Dragoş M; Radu R; Dobre V
    Pneumologia; 2005; 54(2):72-5. PubMed ID: 16536005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro antifungal activity of ajoene on five clinical isolates of Histoplasma capsulatum var. capsulatum].
    Torres J; Romero H
    Rev Iberoam Micol; 2012; 29(1):24-8. PubMed ID: 21635962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endovascular infections caused by Histoplasma capsulatum: a case series and review of the literature.
    Ledtke C; Rehm SJ; Fraser TG; Shrestha NK; Tan CD; Rodriguez ER; Tomford JW; Jain A; Lytle B; Johnston D; Sabik J; Gordon SM; van Duin D
    Arch Pathol Lab Med; 2012 Jun; 136(6):640-5. PubMed ID: 22646271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Histoplasma capsulatum by garlic.
    Fliermans CB
    Mycopathol Mycol Appl; 1973 Jul; 50(3):227-31. PubMed ID: 4729537
    [No Abstract]   [Full Text] [Related]  

  • 14. Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole.
    Wheat LJ; Connolly P; Smedema M; Durkin M; Brizendine E; Mann P; Patel R; McNicholas PM; Goldman M
    J Antimicrob Chemother; 2006 Jun; 57(6):1235-9. PubMed ID: 16627592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi.
    González GM
    Med Mycol; 2009 Feb; 47(1):71-6. PubMed ID: 19101837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the effect of thiabendazole and fungizone on Histoplasma capsulatum in macrophages.
    Subbaratnam S; Miller NG
    Sabouraudia; 1979 Sep; 17(3):331-8. PubMed ID: 394369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deactivation of the dimorphic fungi Histoplasma capsulatum, Blastomyces dermatitidis and Coccidioides immitis using hydrogen peroxide vapor.
    Hall L; Otter JA; Chewins J; Wengenack NL
    Med Mycol; 2008 Mar; 46(2):189-91. PubMed ID: 18324500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUSCEPTIBILITY TO AMPHOTERICIN B OF PHAGOCYTOSED YEAST CELLS OF HISTOPLASMA CAPSULATUM.
    BAUM GL; ARTIS D
    Am J Med Sci; 1965 Feb; 249():211-5. PubMed ID: 14257314
    [No Abstract]   [Full Text] [Related]  

  • 19. A concentration and cultural method for the enhanced isolation of Histoplasma capsulatum from sputum.
    Garrison RG; Gordon L
    Health Lab Sci; 1971 Oct; 8(4):231-7. PubMed ID: 5115118
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cutaneous Histoplasmosis and AIDS].
    Reyes M; Arenas LR; Pichardo P; Vick R; Torres A; Zacarías R
    Gac Med Mex; 2003; 139(3):270-5. PubMed ID: 12872420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.